Bazaar Alan Lee 4
4 · Orthofix Medical Inc. · Filed May 12, 2025
Insider Transaction Report
Form 4
Bazaar Alan Lee
Director
Transactions
- Purchase
Common Stock
2025-05-09$12.62/sh+1,990$25,120→ 26,733 total - Purchase
Common Stock
2025-05-12$12.59/sh+2,000$25,172→ 28,733 total
Footnotes (3)
- [F1]Reflects the weighted average purchase price. The range of prices for these transactions was $12.56 to $12.68. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 24,088 previously reported deferred stock units and an aggregate of 655 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2024 and 4/30/2025.
- [F3]Reflects the weighted average purchase price. The range of prices for these transactions was $12.55 to $12.60. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.